Genpact (NYSE:G - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 3.520-3.590 for the period, compared to the consensus EPS estimate of 3.450. The company issued revenue guidance of $5.0 billion-$5.1 billion, compared to the consensus revenue estimate of $5.1 billion. Genpact also updated its Q1 2025 guidance to 0.790-0.800 EPS.
Genpact Stock Down 1.1 %
Shares of Genpact stock traded down $0.58 during trading on Monday, reaching $54.37. 2,640,296 shares of the company traded hands, compared to its average volume of 1,505,227. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. Genpact has a 1-year low of $30.23 and a 1-year high of $56.76. The company has a 50 day moving average price of $45.09 and a 200-day moving average price of $41.41. The firm has a market capitalization of $9.59 billion, a PE ratio of 19.14, a P/E/G ratio of 1.63 and a beta of 1.20.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.61%. As a group, equities research analysts expect that Genpact will post 3.08 earnings per share for the current fiscal year.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date is Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is presently 23.94%.
Wall Street Analysts Forecast Growth
G has been the topic of a number of research reports. Robert W. Baird boosted their target price on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $45.00 to $60.00 in a report on Friday. Needham & Company LLC upped their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday. Finally, Mizuho upped their price objective on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $48.44.
Read Our Latest Stock Report on G
Insider Transactions at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $11,926,218.40. This trade represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 35,058 shares of company stock worth $1,558,675 in the last quarter. 2.80% of the stock is currently owned by corporate insiders.
Genpact Company Profile
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.